Biden's enhanced Affordable Care Act subsides lowered costs for millions. Trump could let the subsides expire in 2025.

My wife and I looked into Medicare Advantage plans and discovered it wouldn't make sense for us -- be careful before ...

Whether millions gain access to breakthrough anti-obesity treatments may depend on Kennedy, Mehmet Oz and other key players ...

In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body ...

Insurance companies have to pay for PrEP under federal rules, but some skirt the requirement for free access to the treatment ...

However, now, one-third of Nebraska hospitals, like Great Plains, are no longer accepting some or all Medicare Advantage ...

While recent advances in medicine have created prescription anti-obesity GLP-1 medications — like Ozempic, Wegovy, and ...

President-elect Donald Trump has nominated Dr. Mehmet Oz to lead the Centers for Medicare and Medicaid Services (CMS), ...

As Iowa grapples with an ominous physician shortage, health care leaders are focusing their attention on recruitment and ...

North Carolina stopped covering weight loss drugs such as Ozempic for state employees without diabetes. But it extended ...

Trump's controversial administration nominees signal global ramifications for drug regulation, health funding and pharmaceutical investment.

The US election means new American policy inside and out. Healthcare investors anxiously wonder how the sector will perform ...